Skip to Content

Emergent BioSolutions Inc EBS

Morningstar Rating
$2.01 −0.06 (2.90%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EBS is trading at a 44% discount.
Price
$2.07
Fair Value
$5.58
Uncertainty
Extreme
1-Star Price
$82.17
5-Star Price
$2.87
Economic Moat
Qww
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EBS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.07
Day Range
$1.962.15
52-Week Range
$1.8116.66
Bid/Ask
$2.00 / $2.05
Market Cap
$104.13 Mil
Volume/Avg
1.8 Mil / 1.9 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.09
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
2,500

Valuation

Metric
EBS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.09
Price/Cash Flow
Price/Earnings
EBS

Financial Strength

Metric
EBS
Quick Ratio
0.55
Current Ratio
1.12
Interest Coverage
−7.06
Quick Ratio
EBS

Profitability

Metric
EBS
Return on Assets (Normalized)
−10.42%
Return on Equity (Normalized)
−22.34%
Return on Invested Capital (Normalized)
−9.80%
Return on Assets
EBS

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AWdkq$81.2 Bil
MKKGY
Merck KGaA ADRJlqxp$76.0 Bil
HLN
Haleon PLC ADRLqpz$38.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKtfz$11.3 Bil
VTRS
Viatris IncXnbb$11.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVjcnf$10.8 Bil
CTLT
Catalent IncNslvry$7.1 Bil
PRGO
Perrigo Co PLCCjrgl$4.1 Bil
ALKS
Alkermes PLCLfjvm$3.9 Bil
PBH
Prestige Consumer Healthcare IncKnptwm$2.8 Bil